NCT05927558View on ClinicalTrials.gov

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

RecruitingOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
B-cell Non Hodgkin LymphomaRelapseRefractory Lymphoma
Trial Locations (1)

Unknown

RECRUITING

Ematologia Istituto Nazionale Tumori, Milan

All Listed Sponsors
lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER